Skip to main content

This website is intended exclusively for healthcare professionals residing and/or working in Qatar.

Home | go to homepage
SCIENCE
  • SCIENCE
  • Asthma
  • Atopic Dermatitis
  • Cardiovascular
    • Cardiovascular
    • Atherothrombosis
    • Dyslipidemia
    • Thrombosis
  • Diabetes
  • Eosinophilic Esophagitis
  • Multiple Sclerosis
  • Nasal Polyps
  • Prurigo Nodularis
  • Oncology and Rare Blood Disorder
    • Oncology and Rare Blood Disorder
    • Multiple Myeloma
  • Rare Diseases
  • Vaccines
    • Vaccines
    • Influenza
    • Meningitis
    • Pertussis & Polio
    • RSV
PATIENT SUPPORT
  • PATIENT SUPPORT
  • Atopic Dermatitis
  • Cardiovascular
    • Cardiovascular
    • Act Now for ACS Patients
  • Diabetes
    • Diabetes
    • Tools And Resources
      • Tools And Resources
      • Toujeo Welcome Pack
      • Soliqua Welcome Pack
      • Pre-Ramadan assessment and Risk calculation for diabetic patients during Ramadan
      • Clinical and economic value of SOLIQUA - Pharmacist perspective
  • Nasal Polyps
  • Rare Diseases
PRODUCTS
  • PRODUCTS
  • Amaryl®
  • Apidra®
  • Aprovel®
  • Aubagio®
  • Cerezyme
  • Clexane®
  • Depakine®
  • Dupixent®
    • Dupixent®
    • Atopic Dermatitis
    • Asthma
    • Nasal Polyps
  • Lantus®
  • Lemtrada®
  • Plavix®
  • Praluent®
  • Sarclisa
    • Sarclisa
    • Sarclisa®
    • Sarclisa Kd®
    • Sarclisa Pd®
  • Soliqua®
    • Soliqua®
    • Soliqua®
    • SoliMix Study
    • For a Peaceful Ramadan
    • Soli-Simplify Study
  • Tavanic®
  • Toujeo®
    • Toujeo®
    • Toujeo®
    • For a Peaceful Ramadan
    • Time-in-Range
    • Real world Evidences
  • Zympass®
  • LOGIN
  • SIGN UP
  • SEARCH
    Home | go to homepage
  • LOGIN
  • SIGN UP
  • SEARCH
    Home | go to homepage
    SCIENCE
    • SCIENCE
    • Asthma
    • Atopic Dermatitis
    • Cardiovascular
      • Cardiovascular
      • Atherothrombosis
      • Dyslipidemia
      • Thrombosis
    • Diabetes
    • Eosinophilic Esophagitis
    • Multiple Sclerosis
    • Nasal Polyps
    • Prurigo Nodularis
    • Oncology and Rare Blood Disorder
      • Oncology and Rare Blood Disorder
      • Multiple Myeloma
    • Rare Diseases
    • Vaccines
      • Vaccines
      • Influenza
      • Meningitis
      • Pertussis & Polio
      • RSV
    PATIENT SUPPORT
    • PATIENT SUPPORT
    • Atopic Dermatitis
    • Cardiovascular
      • Cardiovascular
      • Act Now for ACS Patients
    • Diabetes
      • Diabetes
      • Tools And Resources
        • Tools And Resources
        • Toujeo Welcome Pack
        • Soliqua Welcome Pack
        • Pre-Ramadan assessment and Risk calculation for diabetic patients during Ramadan
        • Clinical and economic value of SOLIQUA - Pharmacist perspective
    • Nasal Polyps
    • Rare Diseases
    PRODUCTS
    • PRODUCTS
    • Amaryl®
    • Apidra®
    • Aprovel®
    • Aubagio®
    • Cerezyme
    • Clexane®
    • Depakine®
    • Dupixent®
      • Dupixent®
      • Atopic Dermatitis
      • Asthma
      • Nasal Polyps
    • Lantus®
    • Lemtrada®
    • Plavix®
    • Praluent®
    • Sarclisa
      • Sarclisa
      • Sarclisa®
      • Sarclisa Kd®
      • Sarclisa Pd®
    • Soliqua®
      • Soliqua®
      • Soliqua®
      • SoliMix Study
      • For a Peaceful Ramadan
      • Soli-Simplify Study
    • Tavanic®
    • Toujeo®
      • Toujeo®
      • Toujeo®
      • For a Peaceful Ramadan
      • Time-in-Range
      • Real world Evidences
    • Zympass®
  • LOGIN
  • SIGN UP
  • SEARCH
    • Home
    • Login

    Sanofi Preference Center Login

    Enter your credentials to access your account 

     

    {* #signInForm *} {* signInEmailAddress *} {* currentPassword *}

    Forgot password

    Register
    {* /signInForm *}

    anonymous

    Sign out

    Email Verification Required

    To activate your account, you need to verify your email. Please click on the button below to resend a veritifcation link to the email you registered with. 

    Email Sent!
    Resend Verification email

    Forgot your password?

    To reset your password, please enter the email you are registered with.

     

    {* #forgotPasswordForm *} {* signInEmailAddress *}
    {* /forgotPasswordForm *}

    Reset Your Password

    Please follow the link we emailed you to complete your password reset.

     

    Back to home

    Reset your Password

    {* #changePasswordFormNoAuth *} {* newPassword *} {* newPasswordConfirm *}
    {* /changePasswordFormNoAuth *}

    Your password is now updated

    You have successfully changed your password. 

    Login

    Your password reset link has expired

    To receive a new password reset link, please enter the email you registered with.

    {* #resetPasswordForm *} {* signInEmailAddress *}
    {* /resetPasswordForm *}

    Reset Your Password

    Thank you for your request to reset your password. Please follow the link we emailed you to complete your password reset.

     

    Back to home

    HCP Verification Required

    Enter your credentials to access your account 

     

    Your account is being reviewed and validated. You will receive an email when your account has been approved.

    Back to home

    Home | go to homepage

    SANOFI, Level 3, One JLT, Jumeirah Lake Towers (JLT), DMCC, PO Box 53899, Dubai, UAE |

    Tel.: +971 4 550 3600 | Fax: +971 4 5521050

    For further Medical Information:

    please contact: +971 565776791 or Email: medical-information.gulf@sanofi.com

    To report an adverse event:

    please call: +971 561747001 or Email: Gulf.pharmacovigilance@sanofi.com

    To report any product technical complaints, kindly contact: Email: quality.greatergulf@sanofi.com

     

    MAT-QA-2100056/V4/Oct 2022

    • Legal notice
    • Cookie policy
    • Privacy Policy
    • Sitemap
    • Change country

    YOU WILL NOW BE LEAVING THE SITE

    By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
    Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.

    Continue
    This website is intended exclusively for healthcare professionals residing and/or working in the Qatar.
     
    Please choose if you are a healthcare professional and wish to continue on this site or if you are a member of the public to be redirected to the Sanofi website.